BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 27828677)

  • 1. Innovation, development, and financing of institutions of Higher Education in health.
    Poz MR; Couto MH; Franco TA
    Cad Saude Publica; 2016 Nov; 32Suppl 2(Suppl 2):e00139915. PubMed ID: 27828677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health and innovation: economic dynamics and Welfare State in Brazil.
    Gadelha CA; Braga PS
    Cad Saude Publica; 2016 Nov; 32Suppl 2(Suppl 2):e00150115. PubMed ID: 27828678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scientific and technological capabilities in health-related areas: opportunities, challenges, and interactions with the industrial sector.
    Vargas MA; Britto J
    Cad Saude Publica; 2016 Nov; 32Suppl 2(Suppl 2):e00185214. PubMed ID: 27828683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Building inclusive health innovation systems: lessons from India.
    Abrol D; Sundararaman T; Madhavan H; Joseph KJ
    Cad Saude Publica; 2016 Nov; 32Suppl 2(Suppl 2):e00045215. PubMed ID: 27828673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innovation in healthcare services: notes on the limits of field research.
    Costa LS
    Cad Saude Publica; 2016 Nov; 32Suppl 2(Suppl 2):e00151915. PubMed ID: 27828679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health, development and innovation: a contribution of the critical theory of technology to the discussion.
    Souza LE
    Cad Saude Publica; 2016 Nov; 32Suppl 2(Suppl 2):e00029615. PubMed ID: 27828671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health technology assessment (HTA) organizations: dimensions of the institutional and political framework.
    Novaes HM; Soárez PC
    Cad Saude Publica; 2016 Nov; 32Suppl 2(Suppl 2):e00022315. PubMed ID: 27828669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development, health, and international policy: the research and innovation dimension.
    Buss PM; Chamas C; Faid M; Morel C
    Cad Saude Publica; 2016 Nov; 32Suppl 2(Suppl 2):e00046815. PubMed ID: 27828674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telemedicine: challenges to dissemination in Brazil.
    Maldonado JM; Marques AB; Cruz A
    Cad Saude Publica; 2016 Nov; 32Suppl 2(Suppl 2):e00155615. PubMed ID: 27828681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare systems, the State, and innovation in the pharmaceutical industry.
    Delgado IJ
    Cad Saude Publica; 2016 Nov; 32Suppl 2(Suppl 2):e00037415. PubMed ID: 27828672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development policy for the Brazilian health industry and qualification of national public laboratories.
    Viana AL; Silva HP; Ibañez N; Iozzi FL
    Cad Saude Publica; 2016 Nov; 32Suppl 2(Suppl 2):e00188814. PubMed ID: 27828684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The link between industry and social interests in health in Brazil's National Health Innovation System: the experience of the Brazilian National Institute of Traumatology and Orthopedics (INTO).
    Vianna CM; Fermam MK; Rodrigues MP; Mosegui GB
    Cad Saude Publica; 2016 Nov; 32Suppl 2(Suppl 2):e00189414. PubMed ID: 27828685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From health plan companies to international insurance companies: changes in the accumulation regime and repercussions on the healthcare system in Brazil.
    Bahia L; Scheffer M; Tavares LR; Braga IF
    Cad Saude Publica; 2016 Nov; 32Suppl 2(Suppl 2):e00154015. PubMed ID: 27828680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Windows of opportunities and technological innovation in the Brazilian pharmaceutical industry.
    Tigre PB; Nascimento CV; Costa LS
    Cad Saude Publica; 2016 Nov; 32Suppl 2(Suppl 2):e00103315. PubMed ID: 27828675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking control: challenges and achievements.
    Silva LC; Araújo AJ; Queiroz ÂM; Sales MD; Castellano MV;
    J Bras Pneumol; 2016; 42(4):290-298. PubMed ID: 27832238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Policies for control and prevention of infections related to healthcare assistance in Brazil: a conceptual analysis.
    Oliveira HM; Silva CP; Lacerda RA
    Rev Esc Enferm USP; 2016; 50(3):505-11. PubMed ID: 27556723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network as transconcept: elements for a conceptual demarcation in the field of public health.
    Amaral CE; Bosi ML
    Rev Saude Publica; 2016 Aug; 50():51. PubMed ID: 27556965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging arboviruses and public health challenges in Brazil.
    Lima-Camara TN
    Rev Saude Publica; 2016 Jun; 50():. PubMed ID: 27355468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innovation and communicative action: health management networks and technologies.
    Rivera FJ; Artmann E
    Cad Saude Publica; 2016 Nov; 32Suppl 2(Suppl 2):e00177014. PubMed ID: 27828682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Information systems for health: an analysis of design from a public policy perspectiveSistemas de informação para a saúde: uma análise do design na perspectiva das políticas públicas].
    D'Agostino M; Marti MC; Jaime F; Garcia Saiso S
    Rev Panam Salud Publica; 2022; 46():e35. PubMed ID: 35509643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.